Home Depot Builds O...
Health Care: Health Services
Response Genetics Inc. (RGDX: NASDAQ)
$1.38 -0.13 | -8.61%
05/21/13 - 09:33 AM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -7.76M | -5.70M | -4.67M | -9.34M |
| Operating Gains/Losses | 0.00 | 11.79K | 1.85K | -48.62K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -2.66M | -612.99K | -2.98M | 136.55K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -301.40K | 245.38K | 518.05K | 182.12K |
| (Decrease) Increase In Other Current Liabilities | -812.31K | 94.90K | -664.24K | -693.63K |
| (Increase) Decrease In Other Working Capital | 483.05K | -1.62M | 0.00 | 0.00 |
| Other Non-Cash Items | 2.17M | 2.18M | 1.28M | 986.43K |
| Net Cash From Continuing Operations | -8.01M | -5.08M | -6.49M | -8.41M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -8.01M | -5.08M | -6.49M | -8.41M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 48.62K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -956.56K | -390.78K | -391.52K | -224.30K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -956.56K | -390.78K | -391.52K | -175.69K |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 16.45M | 2.19M | 3.95M | 5.98M |
| Repayment of Long-Term Debt | -147.60K | -61.05K | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 1.00M | 0.00 | 86.62K |
| Net Cash From Financing Activities | 16.30M | 3.13M | 3.95M | 6.06M |
| Effect of Exchange Rate Changes | 4.12K | -73.22K | -8.58K | 41.56K |
| Net Change in Cash & Cash Equivalents | 7.34M | -2.42M | -2.94M | -2.49M |
Portfolios with RGDX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks With Big Insider Buy...
- Userjaysan Portfolio 1
- Usercurry Portfolio 1
- Usercharlesl950 Portfolio 1
- UserWACKJDDUDE Portfolio 1
Latest RGDX Headlines from TheStreet
- Response Genetics, Inc. Announces Fourth Quarter And Year-End 2012 Financial Results 03.21.13 | 07:03 am
- Response Genetics To Present At The 25th Annual ROTH Conference 03.12.13 | 07:03 am
- Response Genetics, Inc. To Release Fourth Quarter And Year-End 2012 Financial Results And Host Conference Call On March 21, 2013 03.07.13 | 07:03 am
- 5 Under-$10 Stocks Setting Up to Trade Higher 11.30.12 | 12:11 pm
- 5 Stocks With Big Insider Buying 09.19.12 | 12:09 pm
- Insiders Trading ODP RGDX EGL BRKR 09.18.12 | 01:09 pm
- Maguire Properties, Compugen: Midday Volume Plays 05.11.10 | 11:05 am
- Director Sells $7.4M Worth of Copart 07.01.09 | 10:07 am
Press Releases for RGDX
- Response Genetics, Inc. To Offer Enhanced ALK Testing Program For Metastatic Lung Cancer Patients - Business Wire 06.28.12 | 08:06 am
- Response Genetics Announces Presentation Of Lung Cancer Study Results At 2012 American Society Of Clinical Oncology Annual Meeting - Business Wire 05.30.12 | 08:05 am
- Response Genetics, Inc. Announces First Quarter Financial Results - Business Wire 05.10.12 | 08:05 am
- Response Genetics, Inc. To Release First Quarter Financial Results And Host Conference Call On May 10, 2012 - Business Wire 05.04.12 | 08:05 am
- Response Genetics, Inc. Announces Year-End And Fourth Quarter Financial Results - Business Wire 03.27.12 | 08:03 am
- Response Genetics, Inc. Announces Appointment Of Stephanie Astrow, Ph.D., As Vice President, Research And Development - Business Wire 03.26.12 | 08:03 am
- Response Genetics, Inc. To Release Fourth Quarter And Full-Year 2011 Financial Results And Host Conference Call On March 27, 2012 - Business Wire 03.21.12 | 08:03 am
- Response Genetics Regains NASDAQ Compliance - Business Wire 02.21.12 | 07:02 am
- Response Genetics To Present At The 22nd Annual UBS Global Healthcare Services Conference - Business Wire 02.06.12 | 07:02 am
- Response Genetics Raises More Than $7.8 Million In Financing - Business Wire 02.02.12 | 07:02 am
Partner Headlines for RGDX
- Benzinga's Small Cap Movers for Friday November 30, 2012 - Benzinga 12.02.12 | 11:12 am
- Glaxo Increases Stake in RGDX - Analyst Blog - NASDAQ 09.18.12 | 09:09 pm
- Response Genetics: This Train Is About To Leave The Station - Seeking Alpha 02.16.12 | 09:02 am
- Response Genetics Stock Soars 31% On $7.8M Offering News - Seeking Alpha 02.03.12 | 08:02 am
- Biomarker Diagnostics Drive Personalized Medicine but Path to Market Still Rife With Hurdles - Seeking Alpha 07.07.10 | 07:07 am
- Three Promising Small-Cap Cancer Plays - Seeking Alpha 05.17.10 | 08:05 am
- Response Genetics: An Earnings Primer - Seeking Alpha 05.12.10 | 06:05 am
- UPDATE 1-Response Genetics inks deal with Glaxo, shares soar - Reuters 05.11.10 | 10:05 am
